Analyst firms · Morgan Stanley · AVRO
Morgan Stanley AVRO price target and rating history
AVROBIO Inc. (AVRO) · Health Care
Morgan Stanley rates AVROBIO Inc. (AVRO) Equal-Weight with a $3 price target, as of its latest action on Jan 5, 2022. It has published 4 rating actions on AVRO since July 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Equal-Weight
- Price target
- $3
- Median target, all firms
- Too few
- Actions on AVRO
- 4
Morgan Stanley price target on AVRO
Every Morgan Stanley rating on AVRO
- Jan 5, 2022
- Nov 19, 2021
- Oct 12, 2021
- Jul 16, 2021
Questions about Morgan Stanley and AVRO
- What is Morgan Stanley's price target for AVRO?
- Morgan Stanley's latest stated price target for AVROBIO Inc. (AVRO) is $3, from its action on Jan 5, 2022.
- What is Morgan Stanley's rating on AVRO?
- Morgan Stanley rates AVRO Equal-Weight, a neutral rating, as of Jan 5, 2022.
- When did Morgan Stanley last change its view on AVRO?
- On Jan 5, 2022, Morgan Stanley cuts its price target to $3 from $7, keeps Equal-Weight.
All Morgan Stanley ratingsAVRO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.